Phase I study of safety and immunogenicity of ADU-623, a live-attenuated listeria monocytogenes vaccine (ΔactA/ΔinlB) expressing EGFRVIII and NY-ESO-1, in patients with who grade III/IV astrocytomas
Crossref DOI link: https://doi.org/10.1186/2051-1426-3-S2-P162
Published Online: 2015-11-04
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Crittenden, Marka
Bahjat, Keith S
Li, Rui
Gore, Pankaj
Fountain, Chris
Hanson, Bill
Skoble, Justin
Lauer, Peter
Murphy, Aimee L
Dubensky, Thomas
Brockstedt, Dirk G
Urba, Walter
Article History
First Online: 4 November 2015